Racial and ethnic minority patients with severe trauma are less likely to receive airlift services compared with White ...
DNSFilter announced today the release of its 2025 Annual Security Report, showcasing an uptick in malicious requests from 2023 to 2024. At internet scale, threats are relentless, but so is the right ...
UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...
RingCentral, Inc. , a global leader in AI-powered trusted business communications for companies of all sizes, today unveiled Studio, a new modern capability of the RingCentral Eventstm platform that ...
The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...
A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs ...
That is because the drug, suzetrigine, made by Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside the brain, blocking pain signals. It cannot get into the brain.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.
Trump has falsely accused agents of abuse in their court-ordered search of his Mar-a-Lago home and of their treatment of Capitol rioters. The FBI and Justice Department declined to comment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback